In Cyprus, the revenue in the Anti-Fibrinolytic Drugs market is anticipated to reach US$2.56m by 2024. It is expected to demonstrate an annual growth rate of 4.84% (CAGR 2024-2029), leading to a ...

The Anti-Fibrinolytic Drugs market in Uruguay is expected to witness significant revenue growth, projected to reach US$8.49m by 2024. Furthermore, the market is anticipated to maintain a steady ...